Evidence map›Paper›PMID 41824801›Full record

ReviewEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2026

Ca2+ signalling in cardiac muscle: the importance of balances.

Ernst Niggli, Ana M Gomez

Abstract readReview
In one paragraph

Review in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ernst NiggliDepartment of Physiology, University of Bern, Bühlplatz 5, 3012 Bern, Switzerland.ORCID 0000-0003-4670-4903
Ana M GomezINSERM UMR-S 1180, Université Paris Saclay, 17 Avenue des Sciences, 91400 Orsay, France.ORCID 0000-0003-0009-2884

Funding

Agence Nationale de la Recherche ANR-19-CE14-0031-01Agence Nationale de la Recherche ANR-23-CE14-0009-02Agence Nationale de la Recherche ANR-24-CE14-0135-04Swiss National Science Foundation 310030-156375Swiss National Science Foundation 31003A-179325
6 · The paper itself

Abstract

In this narrative review, an example of a cardiac arrhythmia with a mechanistically appealing molecular pathomechanism is highlighted. This example will be used to delineate how recent basic science findings, which are summarized, can be used to obtain a deeper understanding of pathological behaviour from the molecular to the cellular level. The condition in question is the highly lethal catecholaminergic polymorphic ventricular tachycardia resulting from a point mutation of the cardiac ryanodine receptor. For this deep dive, the RyR2R420Q phenotype will be discussed in detail. Interestingly, these findings and the conclusions which could be drawn from them were very much unexpected but could be relevant for pharmacological treatments. To make the transition from the molecular and cellular findings to the patient will require the translation across several layers of complexity. Ultimately, such detailed understanding will lead to improved therapies tailored to each individual case and the specific RyR2 mutation carried by a particular family, in the framework of precision medicine.

Indexed as

Calcium SignalingMyocardiumMyocytes, CardiacRyanodine Receptor Calcium Release ChannelTachycardia, VentricularAnimalsDeath, Sudden, CardiacGenetic Predisposition to DiseaseHumansPhenotypePoint MutationPolymorphic Catecholaminergic Ventricular TachycardiaRyanodine Receptor Calcium Release ChannelRyR2 protein, humanArrhythmiasCalcium signallingCardiac electrophysiologyCellular electrophysiologyIon channelsMechanismsRyanodine receptorsSudden cardiac death

Identifiers

PMID41824801
PMCPMC13008502

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.